|
2018/08/08 - |
Diabetes - Transplantation of ω3 PUFA Prevents Obesity and Associated Metabolic Disorders |
|
2018/03/14 - |
AMS - Natural Approaches In Metabolic Syndrome Management |
|
2017/06/06 - |
ABC – PUFA to Metabolic Syndrome Cardiovascular Risk Factors and Lipoprotein |
|
2017/05/22 - |
CDR - Is Fish Oil a Potential Treatment for Diabetic Peripheral Neuropathy? |
|
2017/03/03 - |
JCDR - Omega-3 FA on Lipid Profile in Diabetic Dyslipidaemia |
|
2016/10/10 - |
IJMS - Omega-3 PUFA in Ameliorating the Obesity-Induced Metabolic Syndrome |
|
2016/05/05 - |
EBM - DHA Reverses Genomic and Network Perturbations Elicited by Fructose |
|
2016/04/04 - |
FASEB – Omega-3 LCPUFA and Prevalence of Metabolic Syndrome in Obese |
|
2016/01/27 - |
EJN - LCω3PUFAs Inversely Associated with Incidence of Metabolic Syndrome |
|
2016/01/08 - |
CRFSN - Anti-inflammatory Omegas in Cardiovascular and Metabolic Diseases |
|
2015/09/09 - |
PLEFA - Omega-3 FA in Obesity and Metabolic Syndrome |
|
2014/12/12 - |
LHD – PUFA Supplements for Metabolic Syndrome/Diabetes Population |
|
2014/10/05 - |
MRMC – Omega-3 LC-PUFAs in Pediatric Metabolic Syndrome |
|
2014/09/24 - |
EJCN - Calorie-Restriction and Fish Oil Reduced Severity of MetS |
|
2014/05/05 - |
IJFSN - Interactions Between Prebiotics, Probiotics, PUFA, and Polyphenols |
|
2014/01/05 - |
Athero - Omega-3 PUFAs Improved Endothelial Function and Arterial Stiffness in MetS
|
|
2013/10/10 - |
NutrR - High n-3/n-6 Improves Obesity-Linked Inflammation & Insulin Resistance |
|
2013/08/19 - |
Nutrients – DHA, Key Tool in Prevention of Metabolic Syndrome |
|
2013/07/26 - |
Nutrients – Omega-3s and High Fructose Sugar in Development of Metabolic Syndrome |
|
2013/06/26 - |
Immunity - Omega-3 FA Prevent Inflammation and Metabolic Disorder |
|
2013/05/23 - |
BMCP – Omega-3FA Treatment of Non-Alcoholic Fatty Liver Disease |
|
2013/01/28 - |
ClinS – Omega-3 FAs Decrease Plasma VLDL-TG Concentration |
|
2012/12/22 - |
DiaC –High EPA Decreases Atherogenesis in Obese Patients |
|
2012/11/15 - |
JLR – Niacin and Omega-3 FA in Metabolic Syndrome |
|
2012/09/08 - |
CJPP - Omega-3 FA for the Prevention of Metabolic Syndrome |
|
2012/08/15 - |
BMCC - Omega-3 FA a Neuroprotective Agent for Prophylaxis against PIPN |
|
2012/06/06 - |
BJN - EPA and DHA Benefits for Metabolic Syndrome Patients - Review |
|
2012/05/20 - |
DiaC – Optimal Vitamin D Linked To Lower Heart Disease Death |
|
2012/05/15 - |
JPhy - Omega-3 FA Deficiency Exacerbates Dysfunctions in Insulin Receptor Signaling and Cognition |
|
2011/12/12 - |
JNutr – Plant and Marine Omega-3 in Adults with Metabolic Syndrome |
|
2011/10/21 - |
Athero – Diet Supplemented with LCPUFA Reduces Risk Of Metabolic Syndrome |
|
2011/08/11 - |
NutrM – Omega-3 FA Benefit Insulin Sensitivity for Some Genotypes |
|
2011/08/08 - |
EOP - Metabolic Syndrome: Nature, Therapeutic Solutions And Options |
|
2011/07/15 - |
AdvN – Omega-3 FA Alleviate Adipose Tissue Inflammation and Insulin Resistance
|
|
2011/06/12 - |
Nutrition – Omega-3 FAs to Improve Insulin Sensitivity and Control Body Fat |
|
2011/02/21 - |
LHD – Plasma FA Components Improve Prediction Of Metabolic Syndrome |
|
2011/02/01 - |
JNB - Fish Oil Effects Improve Body Fat Storage And Secretory Functions |
|
2011/01/26 - |
AJCN - Hormonal and Metabolic Effects of PUFA in Women with PCOS |
|
2011/01/12 - |
IJPO – Omega-3 Index, Obesity and Insulin Resistance in Children
|
|
2010/11/01 - |
LHD - PUFAs For Prevention and Management of Chronic Disease Conditions |
|
2010/11/01 - |
MoMed – Omega-3 FA for Improving Metabolic Syndrome and Obesity |
|
2010/10/15 - |
Diabetes - EPA Suited for Treatment of Metabolic Syndrome |
|
2010/09/01 - |
JN – Omega-3 Supplementation with Metabolic Syndrome |
|
2010/09/01 - |
J Pediatr. – Fish Oil Improves Cardio Measures |
|
2010/08/01 - |
CardioT - Nutraceuticals in diabetes and metabolic syndrome |
|
2010/07/01 - |
AM – Omega-3 FA as Adjunctive Therapy for Metabolic Syndrome |
|
2010/07/01 - |
JADA – Omega-3 FA and Future Risk of Metabolic Syndrome |
|
2010/05/05 - |
JNB - Anti-inflammatory EPA and DHA dependent upon time and dose-response |
|
2010/04/04 - |
IJVNR - Protection From a Rise in Triglycerides with Omega-3 FAs |
|
2010/03/01 - |
AJCN - Effects Of Omega-3 FA In Subjects With Type 2 Diabetes Mellitus |
|
2010/02/02 - |
JNut – Leptin Receptor and PUFA Augment Risk of Insulin Resistance and Metabolic Syndrome |
|
2010/01/01 - |
FroN - Dietary Fat and Carbohydrate Composition: Metabolic Disease |
|
2009/12/01 - |
IJMM – Omega-3 FA and The Metabolic Syndrome |
|
2009/10/01 - |
NCP – Metabolic Syndrome and Omega-3 FAs |
|
2009/06/06 - |
BANM - Metabolic Syndrome: Can Nutrition Influence Rebellious Organs? |
|
2009/04/14 - |
DiaC – Sunshine Vitamin and Metabolic Syndrome |
|
2009/01/01 - |
JNSV – Role of EPA in Obesity and Metabolic Syndrome Prevention |
|
2008/11/22 - |
JPEN - Pediatric Obesity: An Inflammatory Condition? |
|
2008/03/20 - |
CardioD – PPARs, Fish Oil Omega-3 Derivatives |
|
2008/02/20 - |
AJCN – Omega-3 Shown To Reduce Adiposity In Women With Type 2 Diabetes |
|
2008/01/22 - |
JACC – Anti-Inflammatory Diet for Prevention of Heart Disease and Diabetes |
|
2007/12/12 - |
APNM - Inflammation, Obesity, And FA Metabolism Contributors to Metabolic Syndrome |
|
2007/09/29 - |
ATVB – EPA’s Benefits in Obesity-Related Metabolic Pathology |
|
2007/09/01 - |
JCS - GOCADAN Study: FA Consumption And Metabolic Syndrome |
|
2007/02/01 - |
CDR – PPAR In Metabolic Syndrome and Type 2 Diabetes |
|
2007/01/01 - |
DiaC – Purified EPA in Metabolic Syndrome |
|
2007/01/01 - |
JOS – ALA, EPA, and DHA in Metabolic Syndrome and Type 2 Diabetes |
|
2006/06/01 - |
AJCN - Recommends global consideration of fish oil for metabolic syndrome |
|
2006/06/01 - |
MSRD – Omega-3 FA and Metabolic Syndrome, Infertility, and Pregnancy |
|
2004/10/10 - |
NMCD - The Metabolic Syndrome and Inflammation |
|
1994/09/09 - |
JNut - Dietary Fats, Membrane Phospholipids And Obesity |